GRTX Stock News

Popular stocks:

NVIDIA

TOP Stocks:

Shares of other companies:

The Bank of New York Mellon

Array Technologies

Weidai

Pioneer Power Solutions

Galera Therapeutics (GRTX) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 6, 2023 (07:10)

Sector: Healthcare

The share price of Galera Therapeutics, Inc. (GRTX) now

Latest session on the 5th of December for

Galera Therapeutics, Inc. is positive

Trading Volume: 1396764

Open: 0.14 / High: 0.146 / Low: 0.132

What analysts predict: $0.38

52-week High/Low: $3.59 / $0.085

50/200 Day Moving Average: $0.165 / $1.657

This figure corresponds to the Average Price over the previous 50/200 days. For Galera Therapeutics stocks, the 50-day moving average is the resistance level today.

For Galera Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Galera Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Galera Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Galera Therapeutics share be worth in 2024 - 2028?

When should I take profit in Galera Therapeutics stock? When should I record a loss on Galera Therapeutics stock? What are analysts' forecasts for Galera Therapeutics stock? What is the future of Galera Therapeutics stock? We forecast Galera Therapeutics stock performance using neural networks based on historical data on Galera Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Galera Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Galera Therapeutics shares. This happens once a day.

Historical and forecast chart of Galera Therapeutics stock

The chart below shows the historical price of Galera Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Galera Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Galera Therapeutics is a clinical-grade American biopharmaceutical company that specializes in the development and commercialization of a number of new patented therapeutics to replace radiation therapy for cancer. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.

Galera Therapeutics daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 08	0.14	0.14	0.15	5.63
Dec 09	0.14	0.14	0.14	3.37
Dec 10	0.15	0.14	0.15	3.67
Dec 11	0.14	0.13	0.14	5.48
Dec 12	0.14	0.14	0.15	6.41
Dec 13	0.14	0.14	0.15	3.99
Dec 14	0.15	0.14	0.15	7.02
Dec 15	0.15	0.14	0.15	7.05
Dec 16	0.14	0.14	0.15	5.59
Dec 17	0.14	0.13	0.14	4.32
Dec 18	0.13	0.12	0.13	7.75
Dec 19	0.13	0.12	0.13	9.13
Dec 20	0.13	0.13	0.14	6.60
Dec 21	0.14	0.13	0.14	5.50
Dec 22	0.14	0.14	0.15	8.54
Dec 23	0.15	0.14	0.15	6.38
Dec 24	0.15	0.14	0.15	5.51
Dec 25	0.15	0.15	0.16	5.87
Dec 26	0.14	0.14	0.15	7.65
Dec 27	0.14	0.14	0.15	5.87
Dec 28	0.14	0.14	0.15	7.04
Dec 29	0.14	0.13	0.15	9.77
Dec 30	0.14	0.14	0.14	5.08
Dec 31	0.14	0.13	0.14	5.03
Jan 01	0.14	0.14	0.15	7.05
Jan 02	0.14	0.14	0.15	7.83
Jan 03	0.14	0.14	0.15	5.74
Jan 04	0.14	0.14	0.14	3.54
Jan 05	0.13	0.13	0.14	9.18
Jan 06	0.13	0.12	0.13	6.35

Galera Therapeutics Daily Price Targets

Galera Therapeutics Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $0.14.
Positive dynamics for Galera Therapeutics shares will prevail with possible volatility of 5.331%.
Pessimistic target level: 0.14
Optimistic target level: 0.15

Galera Therapeutics Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $0.14.
Negative dynamics for Galera Therapeutics shares will prevail with possible volatility of 3.256%.
Pessimistic target level: 0.14
Optimistic target level: 0.14

Galera Therapeutics Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $0.15.
Positive dynamics for Galera Therapeutics shares will prevail with possible volatility of 3.537%.
Pessimistic target level: 0.14
Optimistic target level: 0.15

Galera Therapeutics Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $0.14.
Negative dynamics for Galera Therapeutics shares will prevail with possible volatility of 5.196%.
Pessimistic target level: 0.13
Optimistic target level: 0.14

Galera Therapeutics Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $0.14.
Positive dynamics for Galera Therapeutics shares will prevail with possible volatility of 6.024%.
Pessimistic target level: 0.14
Optimistic target level: 0.15

Galera Therapeutics Stock Forecast 12-13-2023.

Forecast target price for 12-13-2023: $0.14.
Positive dynamics for Galera Therapeutics shares will prevail with possible volatility of 3.835%.
Pessimistic target level: 0.14
Optimistic target level: 0.15

GRTX (GRTX) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan.	0.13	0.11	0.15	23.23
Feb.	0.13	0.11	0.14	19.82
Mar.	0.14	0.12	0.15	19.45
Apr.	0.14	0.13	0.17	22.58
May.	0.13	0.12	0.15	25.11
Jun.	0.12	0.11	0.14	20.44
Jul.	0.11	0.09	0.12	21.68
Aug.	0.11	0.10	0.13	18.02
Sep.	0.12	0.11	0.13	13.64
Oct.	0.11	0.09	0.13	27.92
Nov.	0.09	0.08	0.10	25.05
Dec.	0.08	0.06	0.08	22.79

Full forecast for 2024

Galera Therapeutics forecast for this year

Galera Therapeutics Stock Prediction for Jan 2024

An downtrend is forecast for this month with an optimal target price of $0.131955. Pessimistic: $0.11. Optimistic: $0.15

Galera Therapeutics Stock Prediction for Feb 2024

An downtrend is forecast for this month with an optimal target price of $0.127007. Pessimistic: $0.11. Optimistic: $0.14

Galera Therapeutics Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $0.135897. Pessimistic: $0.12. Optimistic: $0.15

Galera Therapeutics Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $0.144391. Pessimistic: $0.13. Optimistic: $0.17

Galera Therapeutics Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $0.130313. Pessimistic: $0.12. Optimistic: $0.15

Galera Therapeutics Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $0.124123. Pessimistic: $0.11. Optimistic: $0.14

Galera Therapeutics Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $0.110159. Pessimistic: $0.09. Optimistic: $0.12

Galera Therapeutics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $0.11429. Pessimistic: $0.10. Optimistic: $0.13

Galera Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $0.117147. Pessimistic: $0.11. Optimistic: $0.13

Galera Therapeutics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $0.111583. Pessimistic: $0.09. Optimistic: $0.13

Galera Therapeutics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $0.0867555. Pessimistic: $0.08. Optimistic: $0.10

Galera Therapeutics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $0.0763449. Pessimistic: $0.06. Optimistic: $0.08

Galera Therapeutics (GRTX) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.07	0.06	0.08	23.59
Feb	0.09	0.07	0.10	25.57
Mar	0.09	0.07	0.10	23.40
Apr	0.08	0.08	0.10	19.87
May	0.09	0.08	0.11	25.63
Jun	0.09	0.08	0.10	17.48
Jul	0.09	0.08	0.10	18.14
Aug	0.08	0.07	0.09	15.16
Sep	0.06	0.05	0.07	17.89
Oct	0.05	0.05	0.06	24.56
Nov	0.04	0.04	0.05	18.95
Dec	0.05	0.04	0.06	26.47

Full forecast for 2025

Galera Therapeutics (GRTX) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.05	0.04	0.05	10.71
Feb	0.04	0.04	0.04	17.87
Mar	0.04	0.04	0.05	21.90
Apr	0.04	0.04	0.05	25.32
May	0.03	0.03	0.04	25.28
Jun	0.03	0.03	0.04	29.76
Jul	0.03	0.03	0.04	21.57
Aug	0.04	0.04	0.04	14.89
Sep	0.04	0.03	0.04	27.27
Oct	0.04	0.04	0.05	19.33
Nov	0.04	0.04	0.05	29.61
Dec	0.04	0.04	0.05	22.70

Full forecast for 2026

Galera Therapeutics (GRTX) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.04	0.04	0.05	22.32
Feb	0.04	0.03	0.04	22.62
Mar	0.04	0.04	0.05	16.52
Apr	0.03	0.03	0.04	25.28
May	0.04	0.03	0.04	19.28
Jun	0.04	0.03	0.04	22.43
Jul	0.04	0.04	0.05	21.46
Aug	0.04	0.03	0.05	30.02
Sep	0.05	0.04	0.06	28.26
Oct	0.05	0.04	0.05	19.40
Nov	0.05	0.04	0.06	28.03
Dec	0.06	0.06	0.07	16.24

Full forecast for 2027

Galera Therapeutics (GRTX) Monthly Stock Prediction for 2028

Month	Target	Pes.	Opt.	Vol., %
Jan	0.07	0.06	0.08	27.66
Feb	0.09	0.08	0.10	18.52
Mar	0.10	0.09	0.11	24.30
Apr	0.10	0.09	0.11	23.74
May	0.11	0.10	0.12	16.52
Jun	0.10	0.09	0.11	22.20
Jul	0.10	0.09	0.12	26.32
Aug	0.10	0.08	0.12	28.12
Sep	0.11	0.09	0.13	29.42
Oct	0.11	0.09	0.13	26.21
Nov	0.13	0.10	0.14	27.05
Dec	0.12	0.11	0.15	22.03

Full forecast for 2028

Galera Therapeutics information and performance

Galera Therapeutics Address

2 WEST LIBERTY BLVD #100, MALVERN, PA, US

Market Capitalization: 7 201 500 $

Market capitalization of the Galera Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GRTX shares in the company outstanding by the market price of one share.

EBITDA: -54 890 000 $

EBITDA of Galera Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.88

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.348

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 54392000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Mesoblast Limited (MESO)

Berkeley Lights, Inc. (BLI)

Aptevo Therapeutics Inc. (APVO)

Hoth Therapeutics, Inc. (HOTH)

Clover Health Investments, Corp. (CLOV)

Oramed Pharmaceuticals Inc. (ORMP)

Walgreens Boots Alliance, Inc. (WBA)

BioDelivery Sciences International, Inc. (BDSI)

Altamira Therapeutics Ltd. (CYTO)

Natera, Inc. (NTRA)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/GRTX.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/GRTX.svg"> Galera Therapeutics (GRTX) Stock Forecast for 2023 – 2026. Sell or Buy?